Five femtech start-ups leading the fight against cancer

From early diagnosis to drug discovery, these femtech start-ups are on a mission to develop life-saving solutions to beat cancer and improve women’s lives.

Vara

Vara’s software platform aims to mitigate much of the human subjectivity associated with reading mammography results, reducing the repetitive work screening physicians are routinely subjected to.

The AI technology, developed by processing millions of mammograms, has been trained to identify patterns and help radiologists when reviewing mammograms. However, the more images it sees, the more accurate it gets.

While humans would remain at the heart of breast cancer detection, radiologists would be given a clinically meaningful advantage when reviewing a mammogram and have their decisions enhanced.

Lattice Medical

The French biomedical start-up Lattice Medical is developing a disruptive bioabsorbable implant for breast reconstruction and breast augmentation.

The procedure uses autologous fat tissues injected into an absorbable implant allowing high volume reconstruction in one surgery.

This absorbable implant is based on fat tissue growing engineering material made of Calais laces and a 3D shell structure delimiting the reconstruction volume. Breasts are entirely reconstructed by the patient’s tissues and no foreign bodies are introduced.

AOA Dx

AOA Dx is a biotech company that focuses on early-stage ovarian cancer detection.

Co-founded by three experts and passionate women’s health advocates, the start-up is developing a “novel” approach to evaluate tumour marker gangliosides in liquid biopsies and develop new diagnostic tests.

AKRIVIS GD, its early-stage liquid biopsy test for ovarian cancer, has proven excellent sensitivity and specificity in a recent study.

Curiva